Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 4/3/2026Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
  • 4/3/2026XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
  • 4/3/2026Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
  • 4/3/2026BDGene Secures Strategic Financing, Relocates Headquarters to Hangzhou...
  • 4/1/2026Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...
  • 4/1/2026Erasca Secures Worldwide Rights to Joyo's Pan-RAS Molecular Glue with ...
  • 3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
  • 3/31/2026Syneron Bio Closes Major Series B to Advance AI-Driven Macrocyclic Pep...
  • 3/31/2026Biocytogen Licenses RenNano® Antibody Discovery Platform to Taisho Ph...
  • 3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
  • 3/31/2026CK Life Sciences Moves to Fast-Track China Cancer Vaccine Development ...
  • 3/31/2026China's Innovative Drug Out-Licensing Nears Half of 2025 Total in Firs...
  • 3/31/2026Santen Accelerates China Strategy by Moving Earlier Into Global Ophtha...
  • 3/30/2026GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
  • 3/30/2026Kailera Files for IPO to Fund China-Licensed Obesity Pipeline
  • 3/30/2026Insilico Lands Landmark $2.75B Lilly Deal as AI Drug Discovery Momentu...
  • 3/27/2026SK Biopharma Launches Epilepsy Drug Cenobamate in China
  • 3/27/2026GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
  • 3/27/2026Jiangsu Aidea Targets Hong Kong IPO to Accelerate Global Expansion in ...
  • 3/27/2026Insilico and Tenacia Expand AI-Driven Collaboration in CNS Drug Disco...
  • 3/27/2026Pinnacle Medicines Secures $89M Series B to Advance Oral Peptide Pipel...
  • 3/25/2026Castalysis Secures Pre-A Funding to Advance alphaCas Gene Editing Plat...
  • 3/25/2026Cellgenes Raises CNY 100M+ Pre-C to Advance Stem Cell Therapy Pipeline
  • 3/25/2026Gilead Nears $2B Ouro Deal Anchored by China-Origin BCMA/CD3 Asset
  • 3/24/2026Chinese Commerce Minister Meets PhRMA, MNC Executives to Discuss Indus...
  • 3/24/2026Kali Therapeutics Licenses Tri-Specific TCE KT501 to Sanofi in Global ...
  • 3/24/2026WuXi AppTec Leans Further on US Market as Other Revenues Weaken
  • 3/24/2026Novartis Commits $480M to Expand China Footprint
  • 3/23/2026Mabgalaxy Raises Near CNY 100M Angel Round to Advance AI-Driven Antibo...
  • 3/23/2026Everest Medicines Acquires Greater China Rights to Etripamil Nasal Spr...
  • Page:1/26 Total number of articles:762: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group